| 2002068 | p ANCA (Anti-Neutrophil Cytoplasmic Antibody with Reflex to Titer & MPO/PR-3 Antibodies) |
| 2004064 | p16 by Immunohistochemistry
|
| 0070236 | P1NP (Procollagen Type I Intact N-Terminal Propeptide) |
| 2004067 | p21 (Waf1/Cip 1) by Immunohistochemistry
|
| 2004070 | p27 (Kip1) by Immunohistochemistry
|
| 2004522 | p53 by Immunohistochemistry
|
| 0049250 | p53 Tissue Assay, Paraffin
|
| 2005542 | P57 by Immunohistochemistry
|
| 2004073 | p63 by Immunohistochemistry
|
| 2002298 | p16 (CDKN2) Deletion (Chromosome FISH, Interphase)
|
| 0055553 | p190 (BCR-ABL, t(9;22) Translocation Qualitative by RT-PCR)
|
| 0055553 | p210 (BCR-ABL, t(9;22) Translocation Qualitative by RT-PCR)
|
| 0055241 | P450 2D6 Antibody, IgG (Liver-Kidney Microsome - 1 Antibody, IgG) |
| 2002984 | P50 (Oxygen Dissociation (P50) by Hemoximetry) |
| 2004076 | P504S (AMACR) by Immunohistochemistry
|
| 2002298 | p53 (TP53) Deletion (Chromosome FISH, Interphase) |
| 0049250 | p53 Tumor Suppressor Protein (p53 Tissue Assay, Paraffin) |
| 2002298 | p53t(4;14)(p16;q32) (Chromosome FISH, Interphase)
|
| 0090161 | Pacerone (Amiodarone and Metabolite) |
| 0098781 | PAI-1 (Plasminogen Activator Inhibitor 1, Activity) |
| 2004980 | PAI-1 (Plasminogen Activator Inhibitor-1, PAI-1 (SERPINE1) Genotyping)
|
| 2004980 | PAI (Plasminogen Activator Inhibitor-1, PAI-1 (SERPINE1) Genotyping)
|
| 2002742 | Pain Management (Buprenorphine & Metabolites - Confirmation/Quantitation - Serum/Plasma) |
| 2002749 | Pain Management (Buprenorphine & Metabolites - Confirmation/Quantitation - Urine) |
| 2003254 | Pain Management (Drug Screen, Targeted, Serum or Plasma) |
| 0090491 | Pain Management (Drugs of Abuse 5 Panel, Urine - Screen Only) |
| 0092182 | Pain Management (Drugs of Abuse 5 Panel, Urine - Screen with Reflex to Confirmation/Quantitation) |
| 0090492 | Pain Management (Drugs of Abuse 5A Panel, Urine - Screen Only) |
| 0092183 | Pain Management (Drugs of Abuse 5A Panel, Urine - Screen with Reflex to Confirmation/Quantitation) |
| 0090448 | Pain Management (Drugs of Abuse 7 Panel, Urine - Screen Only) |
| 0092184 | Pain Management (Drugs of Abuse 7 Panel, Urine - Screen with Reflex to Confirmation/Quantitation) |
| 0090449 | Pain Management (Drugs of Abuse 7A Panel, Urine - Screen Only) |
| 0092185 | Pain Management (Drugs of Abuse 7A Panel, Urine - Screen with Reflex to Confirmation/Quantitation) |
| 0092420 | Pain Management (Drugs of Abuse 9 Panel, Serum or Plasma - Screen with Reflex to Confirmation/Quantitation)
|
| 0090453 | Pain Management (Drugs of Abuse 9 Panel, Urine - Screen Only) |
| 0092186 | Pain Management (Drugs of Abuse 9 Panel, Urine - Screen with Reflex to Confirmation/Quantitation) |
| 0090454 | Pain Management (Drugs of Abuse 9A Panel, Urine - Screen Only) |
| 0092187 | Pain Management (Drugs of Abuse 9A Panel, Urine - Screen with Reflex to Confirmation/Quantitation) |
| 0090362 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Methadone & Metabolite - Urine) |
| 0091372 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Amphetamine - Serum or Plasma) |
| 0090439 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Amphetamines - Urine) |
| 0093308 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Serum or Plasma) |
| 0090357 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Urine) |
| 0093300 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0090676 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Serum or Plasma)
|
| 0090369 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine) |
| 0090684 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Cocaine & Metabolites - Serum or Plasma) |
| 0090359 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Cocaine Metabolite (Benzoylecgonine) - Urine)
|
| 0092569 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Fentanyl & Metabolite - Serum or Plasma) |
| 0092570 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Fentanyl & Metabolite - Urine) |
| 0090699 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Methadone & Metabolite - Serum or Plasma)
|
| 0092354 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Opiates - Serum or Plasma) |
| 0090364 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Opiates - Urine) |
| 0091571 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Phencyclidine - Serum or Plasma) |
| 0091363 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Propoxyphene & Metabolite - Serum or Plasma)
|
| 0090368 | Pain Management (Drugs of Abuse Confirmation/Quantitation - Propoxyphene & Metabolite - Urine) |
| 0092516 | Pain Management (Drugs of Abuse Panel, Meconium - Screen with Reflex to Confirmation/Quantitation) |
| 0092280 | Pain Management (Drugs of Abuse Test, Alcohol, Urine - Screen with Reflex to Confirmation/Quantitation)
|
| 2002756 | Pain Management (Meperidine & Metabolite - Confirmation/Quantitation - Serum or Plasma) |
| 2002760 | Pain Management (Meperidine & Metabolite - Confirmation/Quantitation - Urine) |
| 2003114 | Pain Management (Methylphenidate & Metabolite - Confirmation/Quantitation - Serum or Plasma) |
| 2003115 | Pain Management (Methylphenidate and Metabolite - Confirmation/Quantitation - Urine) |
| 0092361 | Pain Management (Nicotine & Metabolites, Serum or Plasma) |
| 0092356 | Pain Management (Nicotine & Metabolites, Urine) |
| 2003133 | Pain Management (Tapentadol and Metabolite, Serum or Plasma) |
| 2003128 | Pain Management (Tapentadol and Metabolite, Urine) |
| 2002764 | Pain Management (Tramadol & Metabolites - Confirmation/Quantitation - Serum or Plasma) |
| 2002736 | Pain Management (Tramadol & Metabolites - Confirmation/Quantitation - Urine) |
| 0090439 | Pain Management, MDMA/MDA, Quantitative, Urine |
| 0092280 | Pain Management, Alcohol Metabolite, w/Confirmation, w/medMATCH, Urine |
| 0090439 | Pain Management, Amphetamines, Quantitative, w/ medMATCH, Urine |
| 0090439 | Pain Management, Amphetamines, w/Confirmation w/medMATCH, Urine |
| 0090357 | Pain Management, Barbiturates, Quantitative, w/ medMATCH, Urine |
| 0090357 | Pain Management, Barbiturates, w/Confirmation w/medMATCH, Urine |
| 0090358 | Pain Management, Benzodiazepines, Quantitative, w/ medMATCH, Urine |
| 0090358 | Pain Management, Benzodiazepines, w/Confirmation w/med MATACH, Urine |
| 0090600 | Pain Management, Carisoprodol, w/ medMATCH, Urine |
| 0090055 | Pain Management, Clonazepam Metabolite, Quantitative, w/ medMATCH, Urine |
| 0090359 | Pain Management, Cocaine Metabolite, Quantitative, w/ medMATCH, Urine |
| 0090359 | Pain Management, Cocaine Metabolite,., w/Confirmation w/medMATCH, Urine |
| 0091586 | Pain Management, Heroin Metabolite, Quantitative, Urine |
| 0091586 | Pain Management, Heroin Metabolite, Quantitative, w/ medMATCH, Urine |
| 0091586 | Pain Management, Heroin Metabolite, w/Confirmation, w/medMATCH, Urine |
| 0090369 | Pain Management, Marijuana Metabolite, Quantitative, w/ medMATCH, Urine |
| 0090369 | Pain Management, Marijuana Metabolite, w/Confirmation w/medMATCH, Urine |
| 0090439 | Pain Management, MDMA/MDA w/ Confirmation, w/ medMATCH, Urine |
| 0090439 | Pain Management, MDMA/MDA, Quantitative, w/ medMATCH, Urine |
| 0090362 | Pain Management, Methadone, Quantitative, w/ medMATCH, Urine |
| 0090362 | Pain Management, Methadone, w/ Confirmation w/medMATCH, Urine |
| 0090364 | Pain Management, Opiates Expanded, Quantitative, w/medMATCH, Urine |
| 0090364 | Pain Management, Oxycodone, Quantitative, w/ medMATCH, Urine |
| 0090366 | Pain Management, Phencyclidine, Quantitative, w/ medMATCH, Urine |
| 0090366 | Pain Management, Phencyclidine, w/ Confirmation w/ medMATCH, Urine |
| 0090368 | Pain Management, Propoxyphene, Quantitative, w/ medMATCH, Urine |
| 0090368 | Pain Management, Propoxyphene, w/ Confirmation w/ medMATCH, Urine |
| 2004094 | Paired Helical Filament -Tau (PHF-Tau) by Immunohistochemistry
|
| 0092314 | Palladone (Drugs of Abuse Confirmation/Quantitation - Opiates - Meconium) |
| 0090364 | Palladone (Drugs of Abuse Confirmation/Quantitation - Opiates - Urine) |
| 2004700 | PAM50 Breast Cancer Intrinsic Classifier
|
| 0090074 | Pamelor (Nortriptyline) |
| 0096048 | Pamelor (Antidepressant Panel Quantitation, Urine) |
| 2003433 | Pan Cytokeratin (AE1,3) by Immunohistochemistry
|
| 2004232 | Pancreastatin
|
| 2002461 | Pancreatic Adenocarcinoma (Pancreatobiliary FISH) |
| 2002461 | Pancreatic Cancer (Pancreatobiliary FISH) |
| 0080526 | Pancreatic Elastase, Fecal
|
| 0020804 | Pancreatic Isoamylase (Amylase, Isoenzymes) |
| 0099436 | Pancreatic Polypeptide
|
| 2001961 | Pancreatitis, Hereditary (PRSS1) (Familial Mutation, Targeted Sequencing)
|
| 2002016 | Pancreatitis, Hereditary (PRSS1) Sequencing
|
| 2002005 | Pancreatitis, Idiopathic (CFTR, PRSS1, SPINK1) Sequencing
|
| 2001961 | Pancreatitis, Idiopathic (SPINK1) (Familial Mutation, Targeted Sequencing)
|
| 2002012 | Pancreatitis, Idiopathic (SPINK1) Sequencing
|
| 2002461 | Pancreatobiliary FISH
|
| 0040248 | Panitumumab (Vectibix) (KRAS Mutation Detection)
|
| 2001932 | Panitumumab (Vectibix) (KRAS Mutation Detection with Reflex to BRAF Codon 600 Mutation Detection)
|
| 0090805 | Panwarfarin (Warfarin, Serum or Plasma) |
| 0070120 | PAP (Prostatic Acid Phosphatase) |
| 2004079 | PAP (Prostatic Acid Phosphatase (PAP) by Immunohistochemistry) |
| 8100200 | PAP Smear (Cytology, Pap 1 Slide) |
| 8100205 | PAP Smear (Cytology, Pap 2 Slides) |
| 8100210 | PAP Smear (Cytology, Pap 3 Slides) |
| 8100400 | Pap Test (Cytology, SurePath™ Liquid-Based Pap Test (AutoCyte PREP™ System))
|
| 8100214 | Pap Test (Cytology, SurePath™ Liquid-Based Pap Test (AutoCyte PREP™ System) with Reflex to Human Papillomavirus (HPV) DNA Probe, High Risk)
|
| 8100211 | Pap Test (Cytology, ThinPrep® Pap Test™)
|
| 8100212 | Pap Test (Cytology, ThinPrep® Pap with Reflex to Human Papillomavirus (HPV) DNA Probe, High Risk)
|
| 0092314 | Paracodeine (Drugs of Abuse Confirmation/Quantitation - Opiates - Meconium) |
| 0090364 | Paracodeine (Drugs of Abuse Confirmation/Quantitation - Opiates - Urine) |
| 0092524 | Paradex (Drugs of Abuse Confirmation/Quantitation - Propoxyphene & Metabolite - Meconium) |
| 0091363 | Paradex (Drugs of Abuse Confirmation/Quantitation - Propoxyphene & Metabolite - Serum or Plasma) |
| 0090368 | Paradex (Drugs of Abuse Confirmation/Quantitation - Propoxyphene & Metabolite - Urine) |
| 0092314 | Paragoric (Drugs of Abuse Confirmation/Quantitation - Opiates - Meconium) |
| 0090364 | Paragoric (Drugs of Abuse Confirmation/Quantitation - Opiates - Urine) |
| 0051068 | Parainfluenza Virus 1 Antibody, IgG
|
| 0051070 | Parainfluenza Virus 1 Antibody, IgM
|
| 0051071 | Parainfluenza Virus 2 Antibody, IgG
|
| 0051072 | Parainfluenza Virus 2 Antibody, IgM
|
| 0051082 | Parainfluenza Virus 3 Antibody, IgG
|
| 0051083 | Parainfluenza Virus 3 Antibody, IgM
|
| 0065008 | Parainfluenza Virus 1, 2, 3 Culture (Viral Culture) |
| 0051084 | Parainfluenza Virus Antibodies (1, 2, 3), IgG & IgM
|
| 0091448 | Paral® (Paraldehyde and Metabolite, Urine)
|
| 0091449 | Paral® (Paraldehyde, Serum or Plasma)
|
| 0091448 | Paraldehyde and Metabolite, Urine
|
| 0091449 | Paraldehyde, Serum or Plasma
|
| 0091464 | Paramethadione, Serum or Plasma
|
| 0091463 | Paramethadione, Urine
|
| 0092107 | Paraneoplastic Pemphigus Antibody Screen
|
| 0051226 | Paraneoplastic Syndrome Antibody Panel with Reflex to ANNA Titer, PCCA Titer & Neuronal Immunoblot
|
| 0091461 | Paraphos (Parathion, Serum or Plasma) |
| 0091460 | Paraphos (Parathion, Urine) |
| 0060247 | Parasite Examination, Macroscopic
|
| 0060247 | Parasite Identification |
| 2002272 | Parasites (Ova & Parasite Exam, Fecal (Immunocompromised or Travel History)) |
| 0049025 | Parasites Smear (Giemsa Stain), Blood
|
| 0060247 | Parasitic Examination |
| 2002272 | Parasitology Examination (Ova & Parasite Exam, Fecal (Immunocompromised or Travel History)) |
| 0060046 | Parasitology Stain by Modified Acid-Fast
|
| 0091461 | Parathion, Serum or Plasma
|
| 0091460 | Parathion, Urine
|
| 0070346 | Parathormone (Parathyroid Hormone, Intact) |
| 0070172 | Parathormone (Parathyroid Hormone, Intact with Calcium) |
| 0095611 | Parathyroid Hormone, CAP
|
| 2001491 | Parathyroid Hormone, Fine Needle Aspiration (FNA)
|
| 0070346 | Parathyroid Hormone, Intact
|
| 0070172 | Parathyroid Hormone, Intact with Calcium
|
| 2004118 | Parathyroid Hormone (PTH) by Immunohistochemistry
|
| 0093014 | Parathyroid Hormone-Related Peptide (PTHrP)
|
| 0093014 | Parathyroid Hormone Related Protein (Parathyroid Hormone-Related Peptide (PTHrP)) |
| 2005731 | Parechovirus Detection by RT-PCR
|
| 0091372 | Paremyd (Drugs of Abuse Confirmation/Quantitation - Amphetamine - Serum or Plasma) |
| 0092310 | Paremyd (Drugs of Abuse Confirmation/Quantitation - Amphetamines (Amphetamine & Methamphetamine) - Meconium)
|
| 0090439 | Paremyd (Drugs of Abuse Confirmation/Quantitation - Amphetamines - Urine) |
| 0050596 | Parietal Cell Antibody, IgG
|
| 2002730 | Parkes-Weber Syndrome (RASA1-Related Disorders (RASA1) Sequencing)
|
| 2001961 | Parkes-Weber Syndrome (RASA1) Sequencing (Familial Mutation, Targeted Sequencing)
|
| 0091432 | Parnate (Tranylcypromine, Serum or Plasma) |
| 0096048 | Parnate (Antidepressant Panel Quantitation, Urine) |
| 0091431 | Parnate, Urine (Tranylcypromine, Urine) |
| 0050390 | Parotitis (Mumps Virus Antibody, IgG) |
| 0099589 | Parotitis (Mumps Virus Antibody, IgM) |
| 0054443 | Parotitis (Mumps Virus Antibody IgM, CSF) |
| 0090786 | Paroxetine Quantitation, Serum or Plasma
|
| 0091226 | Paroxetine Quantitation, Urine
|
| 0090778 | Paroxetine Quantitation, Whole Blood
|
| 2004366 | Paroxysmal Nocturnal Hemoglobinuria, High Sensitivity, RBC
|
| 2005006 | Paroxysmal Nocturnal Hemoglobinuria Panel, RBC and WBC
|
| 2005003 | Paroxysmal Nocturnal Hemoglobinuria, WBC
|
| 0093386 | Partial or Complete Hydatidiform Moles (DNA Content/Cell Cycle Analysis, Products of Conception) |
| 0030235 | Partial Thromboplastin Time
|
| 2003266 | Partial Thromboplastin Time 1:1 Mix (Inhibitor Assay, PTT with Reflex to PTT 1:1 Mix, with Reflex to 1-Hour Incubation)
|
| 2003266 | Partial Thromboplastin Time Inhibitor Assay (Inhibitor Assay, PTT with Reflex to PTT 1:1 Mix, with Reflex to 1-Hour Incubation)
|
| 2003266 | Partial Thromboplastin Time (Inhibitor Assay, PTT with Reflex to PTT 1:1 Mix, with Reflex to 1-Hour Incubation)
|
| 2003266 | Partial Thromboplastin Time Mixing Study (Inhibitor Assay, PTT with Reflex to PTT 1:1 Mix, with Reflex to 1-Hour Incubation)
|
| 0030235 | Partial Thromboplastin Time (PTT), Activated (Partial Thromboplastin Time) |
| 0065120 | Parvovirus B 19 Antibodies, IgG & IgM
|
| 0065109 | Parvovirus B 19 Antibodies Seroconversion, IgG & IgM
|
| 0065121 | Parvovirus B 19 Antibody, IgG
|
| 0065122 | Parvovirus B 19 Antibody, IgM
|
| 0060043 | Parvovirus B 19, by PCR
|
| 0060028 | Parvovirus B 19, by PCR, Bone Marrow
|
| 0092314 | Parzone (Drugs of Abuse Confirmation/Quantitation - Opiates - Meconium) |
| 0090364 | Parzone (Drugs of Abuse Confirmation/Quantitation - Opiates - Urine) |
| 0049045 | PAS Stain (Periodic Acid Schiff Stain) |
| 2004082 | Pax-5 by Immunohistochemistry
|
| 0040113 | PAX-FKHR Translocation by RT-PCR
|
| 0091432 | Paxil (Tranylcypromine, Serum or Plasma) |
| 0090786 | Paxil® (Paroxetine Quantitation, Serum or Plasma)
|
| 0091226 | Paxil® (Paroxetine Quantitation, Urine)
|
| 0092520 | Paxipam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Meconium) |
| 0093300 | Paxipam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Paxipam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0020745 | Pb (Lead, Blood (Capillary)) |
| 0020098 | Pb (Lead, Blood (Venous)) |
| 0090336 | Pb (Lead, Hair) |
| 0090338 | Pb (Lead, Nails) |
| 0025060 | Pb (Lead, Urine) |
| 2004250 | PBD (Very Long-Chain and Branched-Chain Fatty Acids Profile) |
| 2002181 | PBG (Porphyrins & Porphobilinogen (PBG), Urine) |
| 0080260 | PBG, Quantitative (Porphobilinogen (PBG), Urine) |
| 0090667 | PBR (Zinc, Whole Blood) |
| 0059444 | PCA (Purkinje Cell Cytoplasmic Antibody by IFA with Reflex to Titer & Immunoblot) |
| 2001999 | PCA3 - Prostate Cancer Biomarker
|
| 0090789 | PCB (Polychlorinated Biphenyls, Blood) |
| 0090800 | PCB (Polychlorinated Biphenyls, Serum) |
| 0059444 | PCCA (Purkinje Cell Cytoplasmic Antibody by IFA with Reflex to Titer & Immunoblot) |
| 0092315 | PCP (Drugs of Abuse Confirmation/Quantitation - Phencyclidine (PCP) - Meconium) |
| 0090366 | PCP (Drugs of Abuse Confirmation/Quantitation - Phencyclidine (PCP) - Urine) |
| 0091571 | PCP (Drugs of Abuse Confirmation/Quantitation - Phencyclidine - Serum or Plasma) |
| 0091403 | PCP (Pentachlorophenol, Serum or Plasma) |
| 0091402 | PCP (Pentachlorophenol, Urine) |
| 2004085 | PD-1 by Immunohistochemistry
|
| 2003172 | PDCD10 (Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication)
|
| 2003160 | PDCD10 (Cerebral Cavernous Malformation (CCM3) Sequencing)
|
| 2002298 | PDGFRα Rearrangement (Chromosome FISH, Interphase)
|
| 2002298 | PDGFRβ Rearrangement (Chromosome FISH, Interphase)
|
| 0020044 | Pediazole (Sulfonamides (Sulfas)) |
| 0090221 | Peganone (Ethotoin) |
| 8209701 | Pelvic Washing for Cytology (Cytology, Body Cavity Fluid) |
| 2004002 | PEM (Muc-1 by Immunohistochemistry) |
| 0091558 | Pemoline, Serum or Plasma
|
| 0092001 | Pemphigoid Panel - Epithelial Basement Membrane Zone IgG & IgA, BP180 & BP230 IgG Antibodies
|
| 0092572 | Pemphigoid, Tissue (Cutaneous Direct Immunofluorescence, Biopsy) |
| 0092572 | Pemphigus (Cutaneous Direct Immunofluorescence, Biopsy) |
| 0092106 | Pemphigus IgA Antibodies
|
| 0090650 | Pemphigus Panel - IgG Epithelial Cell Surface Antibodies and Levels of IgG Desmoglein 1 and Desmoglein 3 Antibodies, Serum
|
| 0091403 | Penta (Pentachlorophenol, Serum or Plasma) |
| 0091403 | Pentachlor (Pentachlorophenol, Serum or Plasma) |
| 0091403 | Pentachlorophenol, Serum or Plasma
|
| 0091402 | Pentachlorophenol, Urine
|
| 0091522 | Pentazocine Quantitation, Serum or Plasma
|
| 0091123 | Pentazocine, Urine
|
| 0090225 | Pentobarbital
|
| 0092311 | Pentobarbital (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Meconium) |
| 0093308 | Pentobarbital (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Serum or Plasma) |
| 0090357 | Pentobarbital (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Urine) |
| 0080001 | Peptidylpeptide Hydrolase (Angiotensin Converting Enzyme, Serum) |
| 0092314 | Percocet (Drugs of Abuse Confirmation/Quantitation - Opiates - Meconium) |
| 0092354 | Percocet (Drugs of Abuse Confirmation/Quantitation - Opiates - Serum or Plasma) |
| 0090364 | Percocet (Drugs of Abuse Confirmation/Quantitation - Opiates - Urine) |
| 0092314 | Percodan (Drugs of Abuse Confirmation/Quantitation - Opiates - Meconium) |
| 0092354 | Percodan (Drugs of Abuse Confirmation/Quantitation - Opiates - Serum or Plasma) |
| 0090364 | Percodan (Drugs of Abuse Confirmation/Quantitation - Opiates - Urine) |
| 8209701 | Pericardial Fluid for Cytology (Cytology, Body Cavity Fluid) |
| 0049045 | Periodic Acid Schiff Stain
|
| 8209701 | Peritoneal Fluid Cytology (Cytology, Body Cavity Fluid) |
| 0099906 | Permitil (Fluphenazine) |
| 0091418 | Permitil® (Phenothiazines, Serum or Plasma - Screen with Reflex to Confirmation/Quantitation)
|
| 0091417 | Permitil® (Phenothiazines, Urine - Screen with Reflex to Confirmation/Quantitation)
|
| 0050596 | Pernicious Anemia (Parietal Cell Antibody, IgG) |
| 0049030 | Peroxidase Stain (Myeloperoxidase Stain) |
| 2004250 | Peroxisomal Disorders (Very Long-Chain and Branched-Chain Fatty Acids Profile) |
| 2004250 | Peroxisome Biogenesis Disorders (Very Long-Chain and Branched-Chain Fatty Acids Profile) |
| 0099985 | Perphenazine
|
| 0091467 | Persantine® (Dipyridamole, Serum or Plasma)
|
| 0091466 | Persantine® (Dipyridamole, Urine)
|
| 0091586 | Persantine (Heroin, Urine - Screen with Reflex to Confirmation/Quantitation) |
| 0096048 | Pertofrane (Antidepressant Panel Quantitation, Urine) |
| 2001774 | Pertussis Antibody (Bordetella pertussis Antibodies, IgA & IgG by ELISA with Reflex to Immunoblot)
|
| 2001775 | Pertussis Antibody (Bordetella pertussis Antibodies, IgA, IgG, & IgM by ELISA with Reflex to Immunoblot)
|
| 2004328 | Pertussis Antibody (Bordetella pertussis Antibodies, IgA, IgG & IgM by Immunoblot)
|
| 2001784 | Pertussis Antibody (Bordetella pertussis Antibodies, IgG & IgM by ELISA with Reflex to Immunoblot)
|
| 2004316 | Pertussis Antibody (Bordetella pertussis Antibody, IgA by Immunoblot)
|
| 2005268 | Pertussis Antibody (Bordetella pertussis Antibody, IgG by ELISA)
|
| 2001768 | Pertussis Antibody (Bordetella pertussis Antibody, IgG by ELISA with Reflex to Immunoblot)
|
| 2004327 | Pertussis Antibody (Bordetella pertussis Antibody, IgG by Immunoblot)
|
| 2001769 | Pertussis Antibody (Bordetella pertussis Antibody, IgM by ELISA with Reflex to Immunoblot)
|
| 2004326 | Pertussis Antibody (Bordetella pertussis Antibody, IgM by Immunoblot)
|
| 0060117 | Pertussis Culture (Bordetella pertussis Culture)
|
| 2004667 | Pertussis Smear (Bordetella pertussis DFA)
|
| 2002756 | Pethanol (Meperidine & Metabolite - Confirmation/Quantitation - Serum or Plasma) |
| 2002760 | Pethanol (Meperidine & Metabolite - Confirmation/Quantitation - Urine) |
| 2002756 | Pethidine (Meperidine & Metabolite - Confirmation/Quantitation - Serum or Plasma) |
| 2002760 | Pethidine (Meperidine & Metabolite - Confirmation/Quantitation - Urine) |
| 0090072 | Pertofrane (Desipramine) |
| 0060182 | PFGE (Bacterial Strain Characterization by Pulsed-Field Gel Electrophoresis) |
| 0092526 | PGH (Pituitary Glycoprotein Hormone) (Alpha Subunit of Pituitary Glycoprotein Hormones) |
| 2003571 | PGP 1 (CD44 by Immunohistochemistry) |
| 2004091 | PGP 9.5 (Protein Gene Product (PGP) 9.5 by Immunohistochemistry) |
| | PGP 9.5/Nerve Fiber (Intraepidermal Nerve Fiber Density Analysis) |
| 0020507 | pH, Body Fluid
|
| 0020518 | pH, Fecal
|
| 0020305 | pH, Urine
|
| 0055553 | Ph1 (BCR-ABL, t(9;22) Translocation Qualitative by RT-PCR)
|
| 2003571 | Phagocytic Glycoprotein (CD44 by Immunohistochemistry) |
| 0097303 | Phagocytophilum Titer (Anaplasma phagocytophilum (HGA) Antibodies, IgG & IgM)
|
| 0097317 | Phagocytophilum Titer (Anaplasma phagocytophilum (HGA) Antibody, IgG)
|
| 0097318 | Phagocytophilum Titer (Anaplasma phagocytophilum (HGA) Antibody, IgM)
|
| 0091578 | Phenacemide, Serum
|
| 0091445 | Phenacemide, Urine
|
| 0091457 | Phenazopyridine, Serum or Plasma
|
| 0091456 | Phenazopyridine, Urine
|
| 0092315 | Phencyclidine (Drugs of Abuse Confirmation/Quantitation - Phencyclidine (PCP) - Meconium) |
| 0090366 | Phencyclidine (Drugs of Abuse Confirmation/Quantitation - Phencyclidine (PCP) - Urine) |
| 0091571 | Phencyclidine (Drugs of Abuse Confirmation/Quantitation - Phencyclidine - Serum or Plasma) |
| 0091418 | Phenergan® (Phenothiazines, Serum or Plasma - Screen with Reflex to Confirmation/Quantitation)
|
| 0091417 | Phenergan® (Phenothiazines, Urine - Screen with Reflex to Confirmation/Quantitation)
|
| 0091556 | Phenergan® (Promethazine Quantitative, Serum or Plasma)
|
| 0091473 | Phenergan® (Promethazine Quantitative, Urine)
|
| 0091304 | Phenmetrazine, Serum or Plasma
|
| 0091238 | Phenmetrazine, Urine
|
| 0090230 | Phenobarbital
|
| 0092311 | Phenobarbital (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Meconium) |
| 0093308 | Phenobarbital (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Serum or Plasma) |
| 0090357 | Phenobarbital (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Urine) |
| 0091551 | Phenobarbital, Free & Total, Serum or Plasma
|
| 0091565 | Phenobarbital, Serum or Plasma
|
| 0092311 | Phenobarbitone (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Meconium) |
| 0093308 | Phenobarbitone (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Serum or Plasma) |
| 0090357 | Phenobarbitone (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Urine) |
| 0091260 | Phenol Exposure, Urine
|
| 0020391 | Phenolphthalein, Fecal
|
| 2003237 | PhenoSense® Entry
|
| 2003235 | PhenoSense® Integrase Inhibitor
|
| 0091418 | Phenothiazines, Serum or Plasma - Screen with Reflex to Confirmation/Quantitation
|
| 0091417 | Phenothiazines, Urine - Screen with Reflex to Confirmation/Quantitation
|
| 0091391 | Phensuximide, Serum or Plasma
|
| 0091444 | Phensuximide, Urine
|
| 0091578 | Phenurone (Phenacemide, Serum) |
| 0091445 | Phenurone (Phenacemide, Urine) |
| 0080336 | Phenylalanine & Tyrosine
|
| 0080315 | Phenylalanine Monitoring, Plasma
|
| 0092315 | Phenylcyclohexylpeperidine (Drugs of Abuse Confirmation/Quantitation - Phencyclidine (PCP) - Meconium)
|
| 0090366 | Phenylcyclohexylpeperidine (Drugs of Abuse Confirmation/Quantitation - Phencyclidine (PCP) - Urine) |
| 0091571 | Phenylcyclohexylpeperidine (Drugs of Abuse Confirmation/Quantitation - Phencyclidine - Serum or Plasma)
|
| 0091455 | Phenylpropanolamine, Serum or Plasma
|
| 0091454 | Phenylpropanolamine, Urine
|
| 0090141 | Phenytek (Phenytoin, Free and Total) |
| 0090090 | Phenytoin
|
| 0090141 | Phenytoin, Free and Total
|
| 0090090 | Phenytoin, Total, Serum |
| 2004094 | PHF-Tau (Paired Helical Filament -Tau (PHF-Tau) by Immunohistochemistry) |
| 0055553 | Philadelphia Chromosome (BCR-ABL, t(9;22) Translocation Qualitative by RT-PCR)
|
| 0055553 | Philadelphia MS (BCR-ABL, t(9;22) Translocation Qualitative by RT-PCR)
|
| 2004115 | Phosphatase and Tensin Homolog (PTEN by Immunohistochemistry)
|
| 0020028 | Phosphate (Phosphorus, Inorganic, Plasma or Serum) |
| 0051590 | Phosphatidylcholine Antibodies, IgG, IgM & IgA
|
| 0051622 | Phosphatidylethanolamine Antibodies, IgG, IgM & IgA
|
| 0080275 | Phosphatidylglycerol
|
| 0051623 | Phosphatidylglycerol Antibodies, IgG, IgM & IgA
|
| 0051624 | Phosphatidylinositol Antibodies, IgG, IgM & IgA
|
| 0050905 | Phosphatidylserine Antibodies, IgG, IgM, & IgA
|
| 0020042 | Phospholipids, Serum or Plasma
|
| 0020028 | Phosphorus, Inorganic, Plasma or Serum
|
| 0020478 | Phosphorus, Urine
|
| 0090045 | Phrenilin Forte (Butalbital) |
| 0090362 | Physeptone (Drugs of Abuse Confirmation/Quantitation - Methadone & Metabolite - Urine) |
| 0092313 | Physeptone (Drugs of Abuse Confirmation/Quantitation - Methadone & Metabolite - Meconium) |
| 0090699 | Physeptone (Drugs of Abuse Confirmation/Quantitation - Methadone & Metabolite - Serum or Plasma) |
| 2005003 | PI-Linked Antigens, Monocytes and Granulocytes (Paroxysmal Nocturnal Hemoglobinuria, WBC) |
| 2004366 | PI-Linked Antigens on RBCs (Paroxysmal Nocturnal Hemoglobinuria, High Sensitivity, RBC) |
| 2005006 | PI-Linked Antigens, RBCs, Monocytes and Granulocytes (Paroxysmal Nocturnal Hemoglobinuria Panel, RBC and WBC)
|
| 0080500 | Pi Typing (Alpha-1-Antitrypsin Phenotype (includes Alpha-1-Antitrypsin)) |
| 2004510 | PIK3CA Mutation Detection
|
| 0070236 | PINP (Procollagen Type I Intact N-Terminal Propeptide) |
| 0060051 | Pinworm
|
| 0060051 | Pinworm Preparation (Pinworm) |
| 0091491 | Piroxicam (Feldene), Serum or Plasma
|
| 0091490 | Piroxicam (Feldene), Urine
|
| 0092526 | Pituitary Glycoprotein Alpha Subunit (Alpha Subunit of Pituitary Glycoprotein Hormones) |
| 0092526 | Pituitary Gonadotropins, Alpha-Subunit (Alpha Subunit of Pituitary Glycoprotein Hormones) |
| 0081312 | PIVKA-II (Protein Induced by Vitamin K Absence or Antagonist II) (Des-gamma-carboxy Prothrombin) |
| 0081055 | PLA2 (Lipoprotein-Associated Phospholipase A2 (PLAC™Test))
|
| 0081055 | PLAC (Lipoprotein-Associated Phospholipase A2 (PLAC™Test))
|
| 2004097 | Placental Alkaline Phosphatase (PLAP) by Immunohistochemistry
|
| 0091009 | Placidyl® (Ethchlorvynol, Serum or Plasma)
|
| 0091470 | Placidyl® (Ethchlorvynol, Urine)
|
| 2004097 | PLAP (Placental Alkaline Phosphatase (PLAP) by Immunohistochemistry) |
| 0080216 | Plasma Catecholamines (Catecholamines Fractionated, Plasma) |
| 2003812 | Plasma Cell (CD138 (Syndecan-1) by Immunohistochemistry) |
| 0020058 | Plasma Free Hemoglobin (Hemoglobin, Plasma) |
| 0070105 | Plasma Renin Activity (Renin Activity) |
| 0030110 | Plasma Thromboplastin Antecedent (PTA) (Factor XI, Activity) |
| 0030100 | Plasma Thromboplastin Component (PTC) (Factor IX, Activity) |
| 0098727 | Plasmin Inhibitor (Alpha-2-Antiplasmin, Activity) |
| 0098781 | Plasminogen Activator Inhibitor 1, Activity
|
| 2004980 | Plasminogen Activator Inhibitor-1, PAI-1 (SERPINE1) Genotyping
|
| 2004980 | Plasminogen Activator (Plasminogen Activator Inhibitor-1, PAI-1 (SERPINE1) Genotyping)
|
| 0030190 | Plasminogen Activity
|
| 0030190 | Plasminogen, Functional (Plasminogen Activity) |
| 0030190 | Plasminogen (Plasminogen Activity) |
| 0049025 | Plasmodium Smear (Parasites Smear (Giemsa Stain), Blood) |
| 0030160 | Platelet Aggregation Studies
|
| 0051050 | Platelet Antibodies, Indirect
|
| 0051718 | Platelet Antibodies, Indirect with Reflex to Identification
|
| 0051050 | Platelet Antibodies, Qualitative (Platelet Antibodies, Indirect) |
| 0051718 | Platelet Antibodies, Qualitative (Platelet Antibodies, Indirect with Reflex to Identification) |
| 0051309 | Platelet Antigen 1 Genotyping (HPA-1)
|
| 0051310 | Platelet Antigen 2 Genotyping (HPA-2)
|
| 0051311 | Platelet Antigen 3 Genotyping (HPA-3)
|
| 0051490 | Platelet Antigen 4 Genotyping (HPA-4)
|
| 0051312 | Platelet Antigen 5 Genotyping (HPA-5)
|
| 0051313 | Platelet Antigen 6 Genotyping (HPA-6)
|
| 0051314 | Platelet Antigen 15 Genotyping (HPA-15)
|
| 0051308 | Platelet Antigen Genotyping Panel
|
| 0095614 | Platelet Associated Antibodies, Direct Assay
|
| 0095614 | Platelet Associated Immunoglobulins (IgG & IgM) (Platelet Associated Antibodies, Direct Assay) |
| 2005476 | Platelet Type Von Willebrand Disease (vWD) (von Willebrand Disease, Platelet Type (GP1BA) 4 Mutations)
|
| 0040235 | Platelets
|
| 2003150 | Platelia Aspergillus (Aspergillus Galactomannan Antigen by EIA, Bronchoscopy)
|
| 0060068 | Platelia Aspergillus (Aspergillus Galactomannan Antigen by EIA, Serum)
|
| 0060068 | Platelia Aspergillus Galactomannan (Aspergillus Galactomannan Antigen by EIA, Serum)
|
| 2003595 | Platlet Glycoprotein IIIA (CD61 (Platelet Gycoprotein IIIA) by Immunohistochemistry) |
| 0051104 | Plavix ( Cytochrome P450 2C19 (CYP2C19) 9 Mutations)
|
| 8209701 | Pleural Fluid for Cytology (Cytology, Body Cavity Fluid) |
| 2005555 | PLOD1 (Ehlers-Danlos Syndrome Kyphoscoliotic Form, Type VI (PLOD1) Deletion/Duplication)
|
 | 2005559 | PLOD1 (Ehlers-Danlos Syndrome Kyphoscoliotic Form, Type VI (PLOD1) Sequencing and Deletion/Duplication)
|
| 2003040 | PM/Scl-100 Antibody, IgG, by Immunoblot with Reflex to ANA IFA
|
| 2003040 | PM1 Antibody (PM/Scl-100 Antibody, IgG, by Immunoblot with Reflex to ANA IFA) |
| 2002363 | PML/RARα FISH
|
| 2002298 | PML/RARα Fusion (Chromosome FISH, Interphase)
|
| 2002871 | PML-RARA Translocation, t(15;17) by RT-PCR, Quantitative
|
| 0051737 | PMS2 (HNPCC/Lynch Syndrome (PMS2) Sequencing and Deletion/Duplication)
|
| 0050725 | Pneumococcal Antibodies (Streptococcus pneumoniae Antibodies, IgG (14 serotypes))
|
| 0061162 | Pneumococcal Antigen (Streptococcus pneumoniae Antigen, CSF) |
| 0060228 | Pneumococcal Antigen (Streptococcus pneumoniae Antigen, Urine)
|
| 0060052 | Pneumocystis carinii DFA (Pneumocystis jiroveci DFA)
|
| 2004103 | Pneumocystis jiroveci by Immunohistochemistry
|
| 0060052 | Pneumocystis jiroveci DFA
|
| 0060054 | Poliovirus Antibodies
|
| 0065008 | Poliovirus Culture (Viral Culture) |
| 0050249 | Poliovirus (Enterovirus Detection by RT-PCR) |
| 0090789 | Polychlorinated Biphenyls, Blood
|
| 0090800 | Polychlorinated Biphenyls, Serum
|
| 2004002 | Polymorphic Epithelial Mucin (Muc-1 by Immunohistochemistry) |
| 2002304 | Polyomavirus (BK Virus, Quantitative PCR, Blood) |
| 2002310 | Polyomavirus (BK Virus, Quantitative PCR, Urine) |
| 0095302 | Polyunsaturated Fatty Acids (Fatty Acids Profile, Essential (C12-C22)) |
| 2005631 | Porcine Heparin (Serotonin Release Assay (Heparin Dependent Platelet Antibody), Unfractionated Heparin)
|
| 0099550 | Porphobilinogen (PBG) Deaminase, Erythrocyte
|
| 0080260 | Porphobilinogen (PBG), Urine
|
| 0080260 | Porphyria, Acute (Porphobilinogen (PBG), Urine) |
| 0092572 | Porphyria & Pseudoporphyria, Tissue (Cutaneous Direct Immunofluorescence, Biopsy) |
| 0092012 | Porphyria Cutanea Tarda (PCT) (Porphyrins Profile, Plasma) |
| 0099550 | Porphyria Enzyme (Phorphobilinogen (PGB) Deaminase, Erythrocyte) |
| 2002181 | Porphyrins & Porphobilinogen (PBG), Urine
|
| 0099824 | Porphyrins, Fecal
|
| 2002058 | Porphyrins, Fractionated, Quantitative, 24-Hour (Porphyrins, Fractionation & Quantitation, Urine) |
| 2002058 | Porphyrins, Fractionation & Quantitation, Urine
|
| 0092012 | Porphyrins Profile, Plasma
|
| 2002181 | Porphyrins, Quantitative, 24-Hour Urine (Porphyrins & Porphobilinogen (PBG), Urine) |
| 0080429 | Porphyrins, Serum Total
|
| 0020610 | Porphyrins, Whole Blood (FEP) |
| 0020605 | Porphyrins, Whole Blood (ZPP) (Zinc Protoporphyrin (ZPP), Whole Blood) |
| 0020614 | Porphyrins, Whole Blood (ZPP), Industrial (Zinc Protoporphyrin (ZPP), Whole Blood Industrial) |
| 2001739 | Posaconazole, Quantitation by LC-MS/MS
|
| 2001739 | Posanconazole (Posaconazole, Quantitation by LC-MS/MS) |
| 0098581 | Post Prostatectomy (Prostate Specific Antigen, Ultrasensitive) |
| 0095798 | Post Transplant CD2 and CD3 Monitoring, Percent and Absolute (Lymphocyte Transplantation Profile) |
| 0020380 | Potassium, Fecal
|
| 0020155 | Potassium, Fluid
|
| 0020002 | Potassium, Plasma or Serum
|
| 0020849 | Potassium, Urine
|
| 0090148 | Poxi (Librium and Nordiazepam) |
| 0092520 | Pozapam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Meconium) |
| 0093300 | Pozapam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Pozapam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0091455 | PPA (Phenylpropanolamine, Serum or Plasma) |
| 0091454 | PPA (Phenylpropanolamine, Urine) |
| 0050527 | PR3 IgG Antibodies (Serine Protease 3 Antibody) |
| 2005077 | Prader-Labhart-Willi Syndrome (Angelman Syndrome and Prader-Willi Syndrome by Methylation) |
| 2005077 | Prader-Willi Syndrome (Angelman Syndrome and Prader-Willi Syndrome by Methylation) |
| 2004279 | Prandin (Sulfonylurea Hypoglycemics Panel (Qualitative), Serum or Plasma) |
| 0092520 | Prasepine (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Meconium) |
| 0093300 | Prasepine (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Prasepine (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0092520 | Prazene (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Meconium) |
| 0093300 | Prazene (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Prazene (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0090672 | Prazepam (Assayed as Nordiazepam)
|
| 0092520 | Prazepam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Meconium) |
| 0093300 | Prazepam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Prazepam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0091489 | Prazosin (Minipress), Serum or Plasma
|
| 0091488 | Prazosin, Urine
|
| 0050435 | Prealbumin, Serum
|
| 0098573 | Prednisolone, Serum or Plasma
|
| 2004263 | PreDx™ Diabetes Risk Profile
|
| 2002554 | Pregabalin, Serum or Plasma
|
| 0020229 | Pregnancy Tests (Beta-hCG, Urine Qualitative) |
| 0092330 | Pregnenolone (Adrenal Steroid Quantitative Panel by LC-MS/MS, Serum or Plasma) |
| 0092334 | Pregnenolone by LC-MS/MS, Serum or Plasma
|
| 0099043 | Prekallikrein Factor, Activity
|
| 0091304 | Preludin® (Phenmetrazine, Serum or Plasma)
|
| 0091238 | Preludin® (Phenmetrazine, Urine)
|
| 0095044 | Prenatal Panel A (Prenatal Reflexive Panel) |
| 0095044 | Prenatal Reflexive Panel
|
| 0090157 | Presamine (Imipramine & Desipramine) |
| 2004199 | Primary Carnitine Deficiency (SLC22A5) Deletion/Duplication
|
| 0051682 | Primary Carnitine Deficiency (SLC22A5) Sequencing
|
| 2004203 | Primary Carnitine Deficiency (SLC22A5) Sequencing and Deletion/Duplication
|
| 0095899 | Primary Immunodeficiency Profile (Lymphocyte Subset Panel 7 - Congenital Immunodeficiencies) |
| 0090202 | Primidone & Metabolite
|
| 0030075 | Proaccelerin (Factor V, Activity) |
| 0050083 | proBrain Natriuretic Peptide, NT
|
| 0090151 | Procainamide & NAPA
|
| 0020763 | Procalcitonin
|
| 0091426 | Prochlorperazine (Compazine®), Serum or Plasma
|
| 0091427 | Prochlorperazine (Compazine®), Urine
|
| 2004106 | Procollagen I by Immunohistochemistry
|
| 0070236 | Procollagen Type I Intact N-Terminal Propeptide
|
| 0030075 | Proconvertin (Factor V, Activity) |
| 0090213 | Prodrug (Mycophenolic Acid) |
| 0093386 | Products of Conception, DNA Content Testing (DNA Content/Cell Cycle Analysis, Products of Conception)
|
| 2003556 | Progenitor Cell (CD34, QBEnd/10 by Immunohistochemistry) |
| 0070110 | Progesterone
|
| 0092332 | Progesterone (17-Hydroxyprogesterone Quantitative by LC-MS/MS, Serum or Plasma) |
| 2004525 | Progesterone Receptor (PR) by Immunohistochemistry
|
| 0091301 | Proglycem (Diazoxide, Serum or Plasma) |
| 0091471 | Proglycem (Diazoxide, Urine) |
| 0090612 | Prograf® (Tacrolimus by Tandem Mass Spectrometry)
|
| 0070112 | Proinsulin
|
| 0070256 | Proinsulin/Insulin Ratio
|
| 0070115 | Prolactin
|
| 0070118 | Prolactin (TRH) (Thyroid Releasing Hormone (TRH) Stimulation of Prolactin, 60 Minutes) |
| 0070119 | Prolactin (TRH) (Thyroid Releasing Hormone (TRH) Stimulation of Prolactin, 90 Minutes) |
| 2004109 | Prolactin by Immunohistochemistry
|
| 0020724 | Prolactin, Dilution Study (Prolactin Macroadenoma) |
| 0020724 | Prolactin Macroadenoma
|
| 0070116 | Prolactin (TRH Stimulation) (Thyroid Releasing Hormone (TRH) Stimulation of Prolactin, 0 Minutes) |
| 0070117 | Prolactin (TRH) (Thyroid Releasing Hormone (TRH) Stimulation of Prolactin, 30 Minutes) |
| 0070115 | Prolactin, Dilution Study |
| 0099906 | Prolixin (Fluphenazine) |
| 0091418 | Prolixin® (Phenothiazines, Serum or Plasma - Screen with Reflex to Confirmation/Quantitation)
|
| 0091417 | Prolixin® (Phenothiazines, Urine - Screen with Reflex to Confirmation/Quantitation)
|
| 0091501 | Proloprim |
| 0091396 | Proloprim (Trimethoprim, Serum or Plasma) |
| 0090045 | Promacet (Butalbital) |
| 0091439 | Promazine, Serum or Plasma
|
| 0091438 | Promazine, Urine
|
| 0091556 | Promethazine Quantitative, Serum or Plasma
|
| 0091473 | Promethazine Quantitative, Urine
|
| 0090045 | Prominol (Butalbital) |
| 0090151 | Pronestyl (Procainamide & NAPA) |
| 0090186 | Propafenone
|
| 0091538 | Propanediol (Propylene Glycol, Serum or Plasma) |
| 0090005 | Propanone (Acetone, Quantitative) |
| 0051720 | Properdin Factor B (Complement Factor B) |
| 0091363 | Propoxyphen (Drugs of Abuse Confirmation/Quantitation - Propoxyphene & Metabolite - Serum or Plasma) |
| 0092524 | Propoxyphene (Drugs of Abuse Confirmation/Quantitation - Propoxyphene & Metabolite - Meconium) |
| 0090368 | Propoxyphene (Drugs of Abuse Confirmation/Quantitation - Propoxyphene & Metabolite - Urine) |
| 0091576 | Propoxyphene Metabolite (Darvocet, Serum or Plasma) |
| 0091589 | Propoxyphene Metabolite (Darvocet, Urine) |
| 0091538 | Propylene Glycol, Serum or Plasma
|
| 0091079 | Propylene Glycol, Urine
|
| 2003326 | Prostate genetic risk (deCODE ProstateCancer™ (Genetic Risk Assessment))
|
| 2004112 | Prostate Specific Antigen by Immunohistochemistry
|
| 2002930 | Prostate Specific Antigen, Complexed
|
| 0080206 | Prostate Specific Antigen, Free Percentage (Includes Free PSA & Total PSA)
|
| 0070121 | Prostate Specific Antigen, Total
|
| 0070234 | Prostate Specific Antigen, Total - Medicare Screening
|
| 0080264 | Prostate Specific Antigen, Total with Reflex to Free PSA (Includes Free Percentage)
|
| 0098581 | Prostate Specific Antigen, Ultrasensitive
|
| 0070120 | Prostatic Acid Phosphatase
|
| 2004079 | Prostatic Acid Phosphatase (PAP) by Immunohistochemistry
|
| 0080500 | Protease Inhibitor Typing (Alpha-1-Antitrypsin Phenotype (includes Alpha-1-Antitrypsin)) |
| 0049250 | Protein 53 (p53 Tissue Assay, Paraffin) |
| 0030113 | Protein C Activity (Protein C Functional) |
| 0030182 | Protein C and S Activity (Protein C & S Panel, Functional) |
| 0030182 | Protein C & S Panel, Functional
|
| 0030116 | Protein C & S Panel, Total, Antigen
|
| 0030111 | Protein C Antigen, Plasma (Protein C, Total Antigen) |
| 0030113 | Protein C, Functional
|
| 2003386 | Protein C, Functional with Reflex to Protein C, Total and Protein S, Free with Reflex to Protein S, Total
|
| 0030041 | Protein C, Functional with Reflex to Protein C, Total Antigen
|
| 0030111 | Protein C Immunologic (Protein C, Total Antigen) |
| 0030041 | Protein C Profile (Protein C, Functional with Reflex to Protein C, Total Antigen) |
| 0030127 | Protein C Resistance (APC Resistance Profile) |
| 0030111 | Protein C, Total Antigen
|
| 0050618 | Protein Electrophoresis (Bence Jones Protein, Quantitative Free Kappa & Lambda Light Chains, Urine) |
| 0050590 | Protein Electrophoresis, CSF
|
| 0050640 | Protein Electrophoresis, Serum
|
| 2002109 | Protein Electrophoresis with Interpretation, Serum and Reflex to IFE and QNTIG's (Protein Electrophoresis with Reflex to Immunofixation Electrophoresis Monoclonal Protein Detection, Quantitation & Characterization, IgA, IgG, & IgM, Serum)
|
| 2002109 | Protein Electrophoresis with Reflex to Immunofixation Electrophoresis Monoclonal Protein Detection, Quantitation & Characterization, IgA, IgG, & IgM, Serum
|
| 0090615 | Protein Free Carbamazepine (Carbamazepine, Free and Total) |
| 0090141 | Protein Free Phenytoin (Phenytoin, Free and Total) |
| 0099310 | Protein Free Valproic Acid (Valproic Acid, Free & Total) |
| 2004091 | Protein Gene Product (PGP) 9.5 by Immunohistochemistry
|
| 0030114 | Protein S Activity, Plasma (Protein S, Functional) |
| 0098894 | Protein S Free, Antigen
|
| 2002269 | Protein S, Free Antigen with Reflex to Protein S, Total Antigen
|
| 0030114 | Protein S, Functional
|
| 2002269 | Protein S Profile (Protein S, Free Antigen with Reflex to Protein S, Total Antigen) |
| 0030112 | Protein S, Total Antigen
|
| 0020502 | Protein, Total, Body Fluid
|
| 0020514 | Protein, Total, CSF
|
| 0020029 | Protein, Total, Plasma or Serum
|
| 0020479 | Protein, Total, Urine
|
| 0050707 | Proteinase 3 Antibodies (MPO/PR-3 (ANCA) Antibodies) |
| 2002722 | Proteus-Like Syndrome (PTEN-Related Disorders (PTEN) Sequencing)
|
| 2002726 | Proteus Syndrome (PTEN-Related Disorders (PTEN) Deletion/Duplication)
|
| 2002722 | Proteus Syndrome (PTEN-Related Disorders (PTEN) Sequencing)
|
| 2004411 | Prothrombin Antibodies, IgG & IgM
|
| 0051302 | Prothrombin Antibody, IgG
|
| 0051303 | Prothrombin Antibody, IgM
|
| 0056060 | Prothrombin (F2) G20210A Mutation
|
| 0030007 | Prothrombin (Factor II, Activity (Prothrombin)) |
| 0030215 | Prothrombin Time
|
| 2003260 | Prothrombin Time 1:1 Mix (Inhibitor Assay, PT with Reflex to PT 1:1 Mix) |
| 2003260 | Prothrombin Time Inhibitor Assay (Inhibitor Assay, PT with Reflex to PT 1:1 Mix) |
| 0030224 | Prothrombin Time/International Normalized Ratio
|
| 2003260 | Prothrombin Time Mixing Study (Inhibitor Assay, PT with Reflex to PT 1:1 Mix) |
| 0030224 | Protime, PT/INR (Prothrombin Time/International Normalized Ratio) |
| 2005898 | Protocadherin 19 (PCDH19) Sequencing
|
| 0090612 | Protopic (Tacrolimus by Tandem Mass Spectrometry) |
| 0099824 | Protoporphyrin (Porphyrins, Fecal) |
| 0092012 | Protoporphyrin (Porphyrins Profile, Plasma) |
| 0020610 | Protoporphyrin, Free Erythrocyte (FEP) |
| 0020605 | Protoporphyrin, Zinc (Zinc Protoporphyrin (ZPP), Whole Blood) |
| 0020614 | Protoporphyrin, Zinc, Industrial (Zinc Protoporphyrin (ZPP), Whole Blood Industrial) |
| 0090106 | Protriptyline
|
| 0090154 | Protriptyline (Tricyclic Antidepressant Identification Quantitative, Serum) |
| 0091312 | Proventil (Albuterol, Serum or Plasma) |
| 0091162 | Proventil (Amantadine (Symmetrel®), Urine)
|
| 0096048 | Prozac (Antidepressant Panel Quantitation, Urine) |
| 0090450 | Prozac (Fluoxetine & Metabolite) |
| 0090102 | Prudoxin (Doxepin & Metabolite) |
| 0080206 | PSA, Free (Prostate Specific Antigen, Free Percentage (Includes Free PSA & Total PSA)) |
| 2004112 | PSA (Prostate Specific Antigen by Immunohistochemistry) |
| 2002930 | PSA (Prostate Specific Antigen, Complexed) |
| 0070121 | PSA (Prostate Specific Antigen, Total) |
| 0098581 | PSA, Third Generation (Prostate Specific Antigen, Ultrasensitive) |
| 0080264 | PSA Total (Prostate Specific Antigen, Total w/ Rflx to Free PSA (Includes Free Percentage)) |
| 2005476 | Pseudo Von Willebrand Disease (vWD) (von Willebrand Disease, Platelet Type (GP1BA) 4 Mutations)
|
| 0020175 | Pseudocholinesterase & Cholinesterase, RBC (Insecticide Exposure Panel) |
| 0020159 | Pseudocholinesterase, Dibucaine Inhibition
|
| 0020167 | Pseudocholinesterase, Total
|
| 0091443 | Pseudoephedrine, Serum or Plasma
|
| 0091442 | Pseudoephedrine, Urine
|
| 0065146 | Pseudomembranous Colitis Toxin Assay (Clostridium difficile Toxins (A & B) by EIA)
|
| 0060216 | Pseudomonas/Acinetobacter Susceptibility Panel (Antimicrobial Susceptibility - Nonfermenter)
|
| 2003260 | PT 1:1 Mix (Inhibitor Assay, PT with Reflex to PT 1:1 Mix) |
| 2003260 | PT Inhibitor Assay (Inhibitor Assay, PT with Reflex to PT 1:1 Mix) |
| 0030224 | PT/International Normalized Ratio (Prothrombin Time/International Normalized Ratio) |
| 2003260 | PT Mixing Study (Inhibitor Assay, PT with Reflex to PT 1:1 Mix) |
| 2004980 | PT PCR (Plasminogen Activator Inhibitor-1, PAI-1 (SERPINE1) Genotyping)
|
| 0030215 | PT (Prothrombin Time) |
| 2004115 | PTEN by Immunohistochemistry
|
| 2002726 | PTEN-Related Disorders (PTEN) Deletion/Duplication
|
| 2001961 | PTEN-Related Disorders (PTEN) (Familial Mutation, Targeted Sequencing)
|
| 2002722 | PTEN-Related Disorders (PTEN) Sequencing
|
| 2002470 | PTEN-Related Disorders (PTEN) Sequencing and Deletion/Duplication
|
| 0070346 | PTH Intact Molecule (Parathyroid Hormone, Intact) |
| 0070172 | PTH Intact Molecule with Calcium (Parathyroid Hormone, Intact with Calcium) |
| 2004118 | PTH (Parathyroid Hormone (PTH) by Immunohistochemistry) |
| 0093014 | PTH Related Peptide (Parathyroid Hormone-Related Peptide (PTHrP)) |
| 0093014 | PTH Related Protein (Parathyroid Hormone-Related Peptide (PTHrP)) |
| 2003266 | PTT 1:1 Mix (Inhibitor Assay, PTT with Reflex to PTT 1:1 Mix, with Reflex to 1-Hour Incubation) |
| 2003266 | PTT Inhibitor Assay (Inhibitor Assay, PTT with Reflex to PTT 1:1 Mix, with Reflex to 1-Hour Incubation)
|
| 2003266 | PTT Mixing Study (Inhibitor Assay, PTT with Reflex to PTT 1:1 Mix, with Reflex to 1-Hour Incubation) |
| 0030235 | PTT (Partial Thromboplastin Time) |
| 2003401 | Pulmonary Arterial Hypertension (BMPR2) Deletion/Duplication
|
| 2001961 | Pulmonary Arterial Hypertension (BMPR2) (Familial Mutation, Targeted Sequencing)
|
| 2003410 | Pulmonary Arterial Hypertension (BMPR2) Sequencing
|
| 2003405 | Pulmonary Arterial Hypertension (BMPR2) Sequencing and Deletion/Duplication
|
| 0060182 | Pulsed-Field Gel Electrophoresis (Bacterial Strain Characterization by Pulsed-Field Gel Electrophore |
| 0091084 | Purinethol® (Mercaptopurine Quantitation, Serum or Plasma)
|
| 0091417 | Purinethol® (Phenothiazines, Urine - Screen with Reflex to Confirmation/Quantitation)
|
| 0059444 | Purkinje Cell Cytoplasmic Antibody by IFA with Reflex to Titer & Immunoblot
|
| 2006167 | Purkinje Cell (Yo) Antibody by IFA with Reflex to Titer and Western Blot, CSF
|
| 0070213 | Pyridinium Crosslinks (Total)
|
| 0080342 | Pyridinoline & Deoxypyridinoline by HPLC
|
| 0091457 | Pyridium® (Phenazopyridine, Serum or Plasma)
|
| 0091456 | Pyridium® (Phenazopyridine, Urine)
|
| 0091547 | Pyridostigmine (Mestinon), Serum or Plasma
|
| 0080111 | Vitamin B6 (Vitamin B6 (Pyridoxal 5-Phosphate))
|
| 0070212 | Pyrilinks-D (Deoxypyridinoline Crosslinks) |
| 0080290 | Pyruvate Kinase
|
| 0080310 | Pyruvate (Pyruvic Acid) |
| 0080312 | Pyruvate (Pyruvic Acid, CSF) |
| 0080310 | Pyruvic Acid
|
| 0080312 | Pyruvic Acid, CSF
|